JYMMiN

Leipzig, Germany

Fitness & Physical Activity Alternative Therapies Behavioral Health Care

Musical euphoria is what we provide to improve peoples life everyday. Our new technology merges musically expressive performance with physical exercise. “Jymmin” takes us back to our origins when music making and physical work were often intertwined. Music and physical exertion traditionally was strongly linked, both in traditional and in Western societies, in so-called work songs. We have recreated this experience in an exercise system, which can be performed individually or in groups. A novel form of musical performance, enabled by innovative music-making technology allows for the embodiment of musical creativity through exercise. The benefits of musical-feedback-training in comparison to conventional motor learning are likely to be a consequence of musical expression drawing partly on motor processes that we also use for communication, which are not exclusively under deliberate control, but to substantial degree involve emotional motor control. There is also scientific evidence that Jymmin very effectively engages endorphin, a cognitive feel-good neuro-transmitter system strongly related to endurance.

✓Source: HealthTech Alpha by Galen Growth

Shareable draft

Check out JYMMiN on @MedStartr Today #MentalWellBeing #Fitness #FitnessPhysicalActivity #AlternativeTherapies #BehavioralHealthCare #MedMo #MedStartrVentures

https://www.medstartr.ai/s/y5rMOLNxXWQ

Get Involved in JYMMiN

🏢Is this your company? Claim This Profile

Join MedStartr to verify with your work email and edit this profile

Company Info

Founded: 2019
Website: jymmin.com/

Disease Areas

Mental Well-Being Fitness

Technologies

Exercise Equipment

🌐Website

MedStartr Engagement Score

The MedStartr Index is a reflection of how the crowds that come to MedStartr everyday to find healthcare innovations reacted. Calculated by our AI agent Fyggy based on algorithms we have been building since 2012 and over 100 different factors, the math is proprietary and complex. Suffice to say, it has been found to be highly correlative with early stage company growth. What you see here is the public version. To learn more or to get deeper access to our predictive data on startup success for your fund or company, click here.

Comments

Comments from new members are shown once the company's team has approved them. Please follow the community rules.

Be the first to comment.

What do you think of JYMMiN?

A HUGE part of what early stage companies, and even late stage ones, need and get on MedStartr is honest feedback from actual patients, clinicians, hospital leaders and industry insiders. It is very easy to get tunnel vision as a founder. Please tell the team that runs this company what you think.

Clinical Benefit Potential

The potential for a project to have a large and significant impact on medical care, treatment, or prevention.

Feasibility

The likelihood that this will provide benefit for patients / care givers and that the founders can execute on their vision and plan.

Innovativeness

The distinguishing features, concept, or technology that differentiates the entry compared to others that already exist and are in widespread use.

Fundability

The reviewers' beliefs that the idea is fundable or can make it to sustainability without outside investment.

Scalability

Some great ideas are destined to failure because they are too complex or too expensive. The reviewer should consider the likelihood that a project as explained, or perhaps with some tweaks, could possibly become a worldwide solution within a reasonable time frame.

Presentation Quality

How well the team presented the idea.

Submit anonymously — my name won't be shown to the team or on this profile

Your scores and comments are shown with your review on this company's profile.